Fundraising FoxCatalio Capital Management — 2026 Investments
6 investments dated 2026 · listed companies and verified rows first · show all
Cortex Robot builds datasets for embodied AI and robotics, including egocentric video data from real workplaces and robot trajectories for training physical intelligence systems.
Advanced ManufacturingAI & Machine LearningData & InfrastructureRoboticsSan Francisco, US
Lucas Ngoo(CEO)in
Co-investorsPioneerRebel FundTranspose Platform ManagementY Combinator468 Capital500 Global+14 more
Enveda operates a drug-discovery platform that analyzes natural samples—primarily plant-derived molecules—using mass spectrometry, AI foundation models, and automated high-throughput labs to identify their chemical structures and therapeutic properties.
AI & Machine LearningBiotechDeep TechBoulder, US
Viswa Colluru(Founder)inDaniel Wee(Executive Officer)Pieter Dorrestein(Founder)Viswa Colluru Pieter Dorrestein(Founder)
BoardRohit Sharma(Director)Zavain Dar(Director)in
Co-investorsAir Street CapitalBoulder VenturesCatalio Capital Management, LPCox EnterprisesFPVGaingels+21 more
__Twitter.png)
Evvy is an AI-powered precision medicine platform using vaginal microbiome testing and analysis to diagnose and treat women's health conditions including vaginal health, fertility, and menopause.
AI & Machine LearningDigital HealthFemTechHealthtech
Priyanka Jain(Founder)inLaine Bruzek(Founder)inPita Navarro(Founder)in
Co-investorsAlumni VenturesAmboy Street VenturesBoxGroupForeground CapitalForerunner VenturesGeneral Catalyst+9 more
.png)
Chronus is a platform that connects employees for guided, AI-assisted conversations focused on career development, mentoring, community building, and change adoption in enterprise organizations.
AI & Machine LearningEnterprise SoftwareFuture of WorkHR TechSaaSNew York, US
Aaron Hurst(Founder)in
Co-investorsEmpire AngelsGaingelsSand Hill AngelsVoyager CapitalAlly Bridge GroupAmed Ventures+6 more
Ratio Therapeutics develops radiopharmaceuticals for oncology, working on targeted radiochemistry, discovery, and preclinical and clinical development.
BiotechHealthtechMedical DevicesBoston, US
John Babich(Director, President & Chief Scientific Officer)inJack Hoppin(Chairman & Chief Executive Officer)inJack Hoppin, Ph.D.(Chairman, Chief Executive Officer)William Cupelo(Chief Business Officer)Matthias Friebe(Chief Technology Officer)inScott Holbrook(Chief Commercial and Manufacturing Officer)in
Somethings connects teenagers with peer mentorship support to address gaps in mental health access in the United States.
Digital HealthHealthtechMental HealthWellness & Fitness
Patrick Gilligan(Founder)in
Co-investorsCatalio Capital Management, LPCoalition OperatorsGaingelsGeneral CatalystMana VenturesPlug and Play Ventures+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.